Healthcare >> CEO Interviews >> October 26, 2004
MICHAEL D. WEBB joined EPIX Pharmaceuticals, Inc., as President and CEO
in December 1994 from Ciba-Corning Diagnostics, a medical instrument
company, where he was most recently Senior Vice President, Worldwide
Marketing and Strategic Planning. During his five-year tenure at Ciba,
Mr. Webb's achievements included the highly successful development and
commercialization of the ACS:180TM immunodiagnostic system and the 800
Series blood gas analyzers. From 1984 to 1989, Mr. Webb was a Senior
Consultant at Booz, Allen & Hamilton, Inc., a consulting company,
specializing in health care and life sciences. Mr. Webb holds an MM
degree in Marketing and Finance from the J.L. Kellogg Graduate School of
Management at Northwestern University. Profile
TWST: Would you begin with an update on EPIX Pharmaceuticals? It's beenabout a year since we last spoke. What's going on at the company that
investors should focus on?
Mr. Webb: It has been a